- Telehealth Visits
- Insurance plan information
Cindy J. Lai, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
Cindy J. Lai, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Massachusetts General Hospital
Internship
- Internal Medicine, Massachusetts General Hospital
Degree
- MD, University of Southern California
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22893%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22893%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 28 reviews
- December 29, 20255 out of 5 Stars
As always, Dr. Lai is attentive, thorough, efficient and effective. I feel fortunate to be in her good hands.
- November 21, 20255 out of 5 Stars
Cindy is great... Always warm and understanding. A good listener
- November 10, 20255 out of 5 Stars
Dr. Lai is always prepared for my visits. She is thorough and knowledgeable. When needed, she works with me on developing a plan that I can follow. I feel that I have time to ask questions and follow up if needed.
- August 19, 20255 out of 5 Stars
As always, Dr. Lai is thorough, efficient, effective, amiable and caring.
- July 16, 20255 out of 5 Stars
Dr. Cindy Lai is the best! She really listens to and cares about me and my health. She is very thorough and I am blessed to have her as my PCP.
- May 12, 20255 out of 5 Stars
Dr. Lai is very affable, attentive, thorough, and efficient. She makes patients feel seen and heard as a whole person.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.